BRIDGEWAY CAPITAL MANAGEMENT, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 68 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$53,000
-28.4%
253,300
-16.5%
0.00%
-50.0%
Q2 2022$74,000
-14.9%
303,3000.0%0.00%0.0%
Q1 2022$87,000
-48.8%
303,3000.0%0.00%
-33.3%
Q4 2021$170,000
-63.4%
303,300
-33.5%
0.00%
-66.7%
Q3 2021$465,000
-33.9%
456,000
-10.5%
0.01%
-30.8%
Q2 2021$703,000
-38.0%
509,250
-23.6%
0.01%
-38.1%
Q1 2021$1,133,000
+208.7%
666,350
+125.0%
0.02%
+162.5%
Q4 2020$367,000
-20.7%
296,150
-9.2%
0.01%
-27.3%
Q3 2020$463,000
+10.5%
326,150
-5.8%
0.01%
+37.5%
Q2 2020$419,000
+2.7%
346,1500.0%0.01%
-11.1%
Q1 2020$408,000
-44.1%
346,1500.0%0.01%
-10.0%
Q4 2019$730,000
-4.2%
346,1500.0%0.01%
-9.1%
Q3 2019$762,000
-13.0%
346,1500.0%0.01%0.0%
Q2 2019$876,000
-27.3%
346,1500.0%0.01%
-26.7%
Q1 2019$1,205,000
+50.6%
346,1500.0%0.02%
+36.4%
Q4 2018$800,000
-40.0%
346,1500.0%0.01%
-15.4%
Q3 2018$1,333,000
+60.4%
346,150
+40.6%
0.01%
+62.5%
Q2 2018$831,000
+41.8%
246,150
-11.8%
0.01%
+33.3%
Q1 2018$586,000
+3.7%
279,1500.0%0.01%0.0%
Q4 2017$565,000
-61.5%
279,150
-12.5%
0.01%
-64.7%
Q3 2017$1,468,000
+114.0%
319,1500.0%0.02%
+112.5%
Q2 2017$686,000
-10.8%
319,150
+30.7%
0.01%
-11.1%
Q1 2017$769,000
+5.1%
244,150
-13.3%
0.01%
-10.0%
Q4 2016$732,000
-33.2%
281,6500.0%0.01%
-37.5%
Q3 2016$1,096,000
+44.6%
281,6500.0%0.02%
+33.3%
Q2 2016$758,000
+10.2%
281,650
+26.1%
0.01%0.0%
Q1 2016$688,000
+76.4%
223,400
+120.5%
0.01%
+71.4%
Q4 2015$390,000
+26.2%
101,3000.0%0.01%
+16.7%
Q3 2015$309,000
-28.1%
101,3000.0%0.01%
-25.0%
Q2 2015$430,000
+10.0%
101,3000.0%0.01%0.0%
Q1 2015$391,000
-42.7%
101,3000.0%0.01%
-50.0%
Q4 2014$682,000
+26.8%
101,300
+3.4%
0.02%
+14.3%
Q3 2014$538,000
-46.5%
98,0000.0%0.01%
-46.2%
Q2 2014$1,005,000
-20.2%
98,000
-6.5%
0.03%
-27.8%
Q1 2014$1,259,000
-1.3%
104,820
-7.1%
0.04%
-7.7%
Q4 2013$1,276,000
+4.4%
112,800
-0.5%
0.04%
-7.1%
Q3 2013$1,222,000
+16.8%
113,400
+0.5%
0.04%0.0%
Q2 2013$1,046,000112,8000.04%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders